Leen Kawas, Athira founder and former CEO (Athira)

Leen Kawas, Alzheimer’s CEO who re­signed in da­ta ma­nip­u­la­tion scan­dal, re­turns to launch in­vest­ment firm with bil­lion­aire

Leen Kawas, the start­up founder and CEO who unit­ed in­vestors be­hind a dark­horse ap­proach to treat­ing Alzheimer’s be­fore re­sign­ing last year in a da­ta ma­nip­u­la­tion scan­dal, is back.

Kawas and bil­lion­aire pri­vate eq­ui­ty in­vestor Richard Kayne an­nounced on Fri­day the launch of Pro­pel Bio, a new in­vest­ment firm fo­cused on “com­pa­nies at var­i­ous stages across the life sci­ence space.”

The pair of­fered few oth­er de­tails about the new firm, and a spokesper­son said that nei­ther would speak on the record or com­ment be­yond the re­lease “to com­ply with SEC reg­u­la­tions.” An SEC fil­ing Fri­day in­di­cat­ed the com­pa­ny planned to raise $150 mil­lion, but did not list any funds raised to date.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.